Quarterly report · Q3
3750.TEDINET S100Q6BK
Period2022-04-01 → 2022-12-31
Filed2023-02-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.7bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.0bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | −¥516m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | −¥296m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | −¥602m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | −¥418m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥271m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | −¥710m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥41m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥723m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥78m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥61m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥723m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥62m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥14.1bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥11.1bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥12.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.0bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.8bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥776m | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥852m | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-80.95 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-18.09 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥6.97 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥10.8 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥6.81 | 2021-04-01 → 2021-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 19.7% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.4% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | −¥116m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥128m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥128m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥224m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.5bn |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2022-12-31 | −¥176m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥1.7bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥1.7bn |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | −¥400m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2021-04-01 → 2021-12-31 | −¥110m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥170m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥170m |
| jpcrp040300-q3r_E05443-000Medical Asset Managemetreportable segment | segment profit | 2021-04-01 → 2021-12-31 | −¥133m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥870m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥870m |
| jpcrp040300-q3r_E05443-000Real Asset Managementreportable segment | segment profit | 2021-04-01 → 2021-12-31 | −¥53m |
| —segment total | revenue | 2021-04-01 → 2021-12-31 | ¥1.0bn |
| —segment total | revenue external | 2021-04-01 → 2021-12-31 | ¥1.0bn |
| —segment total | segment profit | 2021-04-01 → 2021-12-31 | −¥186m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 323
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 1039719000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 1039719000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 169736000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | 869983000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 1039719000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | Prior1YTDDuration | 1039719000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -132671000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | -52982000 | JPY |
| Operating income | Prior1YTDDuration_ReportableSegmentsMember | -185653000 | JPY |
| Operating income | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -110176000 | JPY |
| Operating income | Prior1YTDDuration | -295829000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 127644000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | 1524191000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReportableSegmentsMember | 1651836000 | JPY |
| Revenues from external customers | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 1651836000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | 127644000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | 1524191000 | JPY |
| Net sales | CurrentYTDDuration_ReportableSegmentsMember | 1651836000 | JPY |
| Net sales | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Net sales | CurrentYTDDuration | 1651836000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05443-000MedicalAssetManagemetReportableSegmentsMember | -223616000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q3r_E05443-000RealAssetManagementReportableSegmentsMember | -176272000 | JPY |
| Operating income | CurrentYTDDuration_ReportableSegmentsMember | -399889000 | JPY |
| Operating income | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | -115939000 | JPY |
| Operating income | CurrentYTDDuration | -515828000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-02-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第19期第３四半期（自 2022年10月１日 至 2022年12月31日） | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社サイトリ細胞研究所（旧会社名 ＦＲＡＣＴＡＬＥ株式会社） | |
| Company name in english cover page | FilingDateInstant | Text · Plus | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 堀江 聡寧 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目１番１号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 03－6860－5701 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)経営企画部長 藤村 剛 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都千代田区大手町一丁目１番１号 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |